10x Genomics
TXG
$45.44
Share price
-2.30%
Change (1 day)
7.17%
Change (1 year)
Categories
10x Genomics (TXG) - Net assets
Net assets on the balance sheet as of June 2023 : $0.79 B
According to 10x Genomics
's latest financial reports the company has $0.79 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
10x Genomics - Net assets on balance sheet (from 2018 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.80 B | -1.45% |
| 2021-12-31 | $0.81 B | 10.62% |
| 2020-12-31 | $0.73 B | 75.93% |
| 2019-12-31 | $0.42 B | -290.96% |
| 2018-12-31 | $-0.22 B | 95.53% |
| 2017-12-31 | $-0.12 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $11.77 M | -98.52% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.10 B | -86.25% | 🇬🇧 UK |
 Novavax NVAX | -$0.76 B | -195.11% | 🇺🇸 USA |
 Novocure
NVCR | $0.41 B | -47.60% | Jersey |